Hematology Oncology Scholarship

Scholarship is an important component to our Hematology Oncology Fellowship Program. Our fellows are encouraged to explore diverse research opportunities, including clinical research, quality improvement and review articles with mentorship from faculty members.

Below, we have a repository of a few publications and poster presentations in the last 3 years coming out from our fellows and faculty members.

Discover Our Division's Publications
  1. Bhardwaj PV, Abdou Y. Managing pregnancy-associated breast cancer: A practical approach. Semin Perinatol. 2025 Mar;49(2):152037. doi: 10.1016/j.semperi.2025.152037.
  2. Yunes MJ. Radiation Therapy for Dupuytren Contracture. Pract Radiat Oncol. 2025 Jan 15:S1879-8500(24)00349-7. doi: 10.1016/j.prro.2024.11.010.
  3. Avelino ARM, Pulipati S, Jamouss K, Bhardwaj PV. Updates in Treatment of HER2-positive Metastatic Breast Cancer. Curr Treat Options Oncol. 2024 Nov 9. doi: 10.1007/s11864-024-01277-2.
  4. Bendapudi PK, Foy BH, Mueller SB, Liu J, Feingold LM, Burke KE, Cruz W, Chen MY, Lau ES, Goldberg RL, Tatake I, Wilkinson SC, Carney BJ, Stone JR, Park D, Avelino AR, Hassan S, Andrzejewski C, Ruby KN, Friedman KD, Brunker PAR, Leaf RK, Higgins J, Dzik WH, Stefely JA, Makar RS. Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2024 May 9;390(18):1690-1698. doi: 10.1056/NEJMoa2402567. PMID: 38718359; PMCID: PMC11128310.
  5. Bhardwaj PV, Gupta S, Elyash A, Teplinsky E. Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship. Curr Oncol Rep. 2024 Jan 2. doi: 10.1007/s11912-023-01489-z.
  6. Bhardwaj PV, Abdou Y. Navigating Treatment Pathways in Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies. J Clin Oncol. 2024 Sep 18:JCO2401295. doi: 10.1200/JCO-24-01295.
  7. Diaz FC, Hamparsumian A, Loh KP, Verduzco-Aguirre H, Abdallah M, Williams GR, Hsu T, Soto-Perez-de-Celis E, Elias R. Geriatric Oncology: A 5-Year Strategic Plan. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100044. doi: 10.1200/EDBK_100044.
  8. Sharma N, Loscocco GG, Gangat N, Guglielmelli P, Pardanani A, Vannucchi AM, Alkhateeb HB, Tefferi A, Ho VT. When and how to transplant in myelofibrosis - recent trends. Leuk Lymphoma. 2024 Nov 14:1-19. doi: 10.1080/10428194.2024.2422835.
  9. Smart AC, Yunes MJ, Winkfield KM. Policy Priorities in Cancer Care for Transgender People. JAMA Oncol. 2024 Apr 18. doi: 10.1001/jamaoncol.2024.0451.
  10. Bhardwaj PV, Wang Y, Brunk E, Spanheimer PM, Abdou YG. Advances in the Management of Early-Stage Triple-Negative Breast Cancer. Int J Mol Sci. 2023 Aug 5;24(15):12478. doi: 10.3390/ijms241512478.
  11. Bhardwaj PV, Abdou YG. The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer. Oncologist. 2023 Aug 19:oyad233. doi: 10.1093/oncolo/oyad233.
  12. Bhardwaj PV, Clarke AC, Knee A, Gottlieb AS, Jobbins KA. Representation of Women Among Grand Rounds Speakers at an Academic Health System Early in the COVID-19 Pandemic. Cureus. 2023 Jun 29;15(6):e41150. doi: 10.7759/cureus.41150.
  13. Bhardwaj PV, Dulala R, Rajappa S, Loke C. Breast Cancer in India: Screening, Detection, and Management. Hematol Oncol Clin North Am. 2023 Jun 15:S0889-8588(23)00069-2. doi: 10.1016/j.hoc.2023.05.014.
  14. Bhardwaj PV, Mason H, Kaufman SA, Visintainer P, Makari-Judson G. Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center. Curr Oncol. 2023 May 8;30(5):4861-4870. doi: 10.3390/curroncol30050366.
  15. Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW. Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer. Clin Cancer Res. 2023 May 15:CCR-23-0112. doi: 10.1158/1078-0432.CCR-23-0112.
  16. Sharma N, Liesveld JL. NPM 1 Mutations in AML-The Landscape in 2023. Cancers (Basel). 2023 Feb 12;15(4):1177. doi: 10.3390/cancers15041177.
  17. Sharma N, Wayant C, Neupane K, Lenka J, Berger K, Goodman AM, Booth CM, Prasad V, Mohyuddin GR. Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology. J Cancer Policy. 2023 Feb 9:100411. doi: 10.1016/j.jcpo.2023.100411. Bhardwaj PV, Abdou YG. Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications. Curr Oncol Rep. 2022 Oct 18. doi: 10.1007/s11912-022-01340-x.
  18. Bhardwaj PV, Abdou YG. Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications. Curr Oncol Rep. 2022 Oct 18. doi: 10.1007/s11912-022-01340-x.
  19. Bhardwaj PV, Abraham A, Alluri S (September 08, 2022) Primary Spinal Epidural Diffuse Large B-cell Lymphoma: Case Report and Literature Review. Cureus 14(9): e28934. doi:10.7759/cureus.28934
  20. Gould D, Walker R, Makari-Judson G, Seven M. Experiences of individuals with a variant of uncertain significance on genetic testing for hereditary cancer risks: a mixed method systematic review. J Community Genet. 2022 Jul 12. doi: 10.1007/s12687-022-00600-4.
  21. Makari-Judson G, Viskochil R, Katz D, Barham R, Mertens WC. Insulin resistance and weight gain in women treated for early stage breast cancer. Breast Cancer Res Treat. 2022 May 21. doi: 10.1007/s10549-022-06624-1.
  22. Morin SM, Majhi PD, Crisi GM, Gregory KJ, Franca R, Schalet B, Mason H, Casaubon JT, Cao QJ, Haddad S, Makari-Judson G, Jerry DJ, Schneider SS. Interindividual variation contributes to differential PCB 126 induced gene expression in primary breast epithelial cells and tissues. Ecotoxicol Environ Saf. 2022 Jun 17;241:113722. doi: 10.1016/j.ecoenv.2022.113722.
  23. Sharma N, Reagan PM, Liesveld JL. Cytopenia after CAR-T Cell Therapy-A Brief Review of a Complex Problem. Cancers (Basel). 2022 Mar 15;14(6):1501. doi: 10.3390/cancers14061501.
  24. Pasupula DK, Siddappa Malleshappa SK, Munir MB, Bhat AG, Anandaraj A, Jakkoju A, Spooner M, Koranne K, Hsu JC, Olshansky B, Camm AJ. Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016-2019 national readmission database. Europace. 2022 Nov 9:euac181. doi: 10.1093/europace/euac181.
  25. Patlolla SH, Bhat AG, Sundaragiri PR, Cheungpasitporn W, Doshi RP, Siddappa Malleshappa SK, Pasupula DK, Jaber WA, Nicholson WJ, Vallabhajosyula S. Impact of Active and Historical Cancers on the Management and Outcomes of Acute Myocardial Infarction Complicating Cardiogenic Shock. Tex Heart Inst J. 2022 Sep 1;49(5):e217598. doi: 10.14503/THIJ-21-7598.
  26. Tun SM, Alluri S, Rastegar V, Visintainer P, Mertens W, Makari-Judson G. Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients. Clin Breast Cancer. 2022 Jun 29:S1526-8209(22)00139-2. doi: 10.1016/j.clbc.2022.06.003.
Discover Out Division's Conference Posters and Abstracts
  1. Anisha Karim, Yesenia Greeff, Rawad Elias, Eduardo Nunez. Likelihood of colorectal cancer screening by poor health status: A cross-sectional analysis of the Behavioral Risk Factor Surveillance System 2022. Accepted for Abstract Publication at ASCO Annual Meeting 2025
  2. Kamelah Abushalha, Abinesh Sekar, Peter Silberstein. Clinicopathological features and survival outcomes in patients with high microsatellite instability small intestine cancers: A National Cancer Database analysis. Accepted for Abstract Publication at ASCO Annual Meeting 2025
  3. Divya Solipuram, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. Gender Disparity in Chimeric Antigen Receptor T-cell therapy utilization and outcomes in the United States. Accepted for poster presentation at ASCO Annual Meeting 2024
  4. Divya Solipuram, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. Trends in the thrombotic complications of myeloproliferative neoplasms: A nationwide analysis. Accepted for poster presentation at ASCO Annual Meeting 2024
  5. Prarthna V. Bhardwaj, Sneha Nagesh Rao, Deepak Pasupula, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. The impact of COVID-19 on national trends of hospitalization and outcomes for acute leukemias. Accepted for Abstract Publication at ASCO Annual Meeting 2023
  6. Prarthna V Bhardwaj, Lekha Yadukumar, Ishani Patel, Deepak Pasupula, Chandravathi Loke, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. Did COVID-19 impact national trends of hospitalization and outcomes for neutropenic fever in adults with cancer? Accepted for Abstract Publication at ASCO Annual Meeting 2023
  7. Maryam Naser, Prarthna V Bhardwaj, Fatima Zahid Warriach, Yamna Jadoon, Kush Gupta, Vida Rastegar, Chandravathi Loke, Sudeep Kumar Siddappa Malleshappa. Real-world effectiveness of prophylactic tixagevimab-cilgavimab monoclonal antibodies on incidence and severity of COVID-19 infection in patients with cancer. Accepted for Abstract Publication at ASCO Annual Meeting 2023. Also presented as an oral presentation through the medical student and resident interest group through ASCO
  8. Edison Tsui, Katherine Reeves, Isabella Caruso, Grace Makari-Judson. The impact of COVID-19 on anxiety among breast cancer survivors before, during and after the pandemic. Accepted for Abstract Publication at ASCO Annual Meeting 2023
  9. Prarthna V Bhardwaj, Seth Kaufman, Holly Mason, Paul Visintainer, Grace Makari-Judson. Real-world outcomes of neoadjuvant chemotherapy for breast cancer: Reflections from a community cancer center. Accepted for Abstract Publication at ASCO Annual Meeting 2022

Back to Top